Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 6Active not recruiting 4Unknown 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 2

Interventions

Cisplatin 129Radiotherapy 94Carboplatin 82Fluorouracil 77Paclitaxel 76Cyclophosphamide 76Gemcitabine 71Capecitabine 66Docetaxel 64Doxorubicin 59Oxaliplatin 57Etoposide 57Leucovorin 48Vincristine 46Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Pemetrexed 27Neoadjuvant Therapy 26Irinotecan 25Tamoxifen 24Prednisone 23Methotrexate 21Rituximab 19Vinorelbine 18Radiotherapy, Intensity-Modulated 18Peripheral Blood Stem Cell Transplantation 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Introns × Clear all
NCT03435302 2018-02-19

HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma

Peking University Cancer Hospital & Institute

Phase 3 Unknown
204 enrolled
Dermatologic

Melanoma

NCT00226408 2006-06-21

Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon

Dermatologic Cooperative Oncology Group

Phase 3 Unknown
600 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡